From Alzheimer's Disease to Anxiety, Epilepsy to Schizophrenia: A Comprehensive Dive Into Neuro-Psychiatric Disorders.

Autor:	Grezenko H; Medicine and Surgery, Guangxi Medical University, Nanning, CHN.; Translational Neuroscience, Barrow Neurological Institute, Phoenix, USA., Rodoshi ZN; Medical Education, Mymensingh Medical College, Dhaka, BGD., Mimms CS; Medicine, St. George's University, St. George's, USA., Ahmed M; Psychiatry and Behavioral Sciences, Dow University of Health Sciences, Karachi, PAK., Sabani A; Medicine, St. George's University, St. George's, USA., Hlaing MS; Geriatrics, United Lincolnshire Hospitals NHS Trust, Boston, GBR., Batu BJ; General Practice, St. Paul's Hospital Millennium Medical College, Addis Ababa, ETH., Hundesa MI; Medical Services, Federal Democratic Republic of Ethiopia Ministry of Health, Addis Ababa, ETH., Ayalew BD; Internal Medicine, St. Paul's Hospital Millennium Medical College, Addis Ababa, ETH., Shehryar A; Internal Medicine, Allama Iqbal Medical College, Lahore, PAK., Rehman A; Surgery, Mayo Hospital, Lahore, PAK., Hassan A; Internal Medicine, Mayo Hospital, Lahore, PAK.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Apr 22; Vol. 16 (4), pp. e58776. Date of Electronic Publication: 2024 Apr 22 (Print Publication: 2024).
DOI:	10.7759/cureus.58776
Abstrakt:	This comprehensive narrative review endeavors to dissect the intricate web of neuropsychiatric disorders that significantly impact cognition, emotion regulation, behavior, and mental health. With a keen focus on Alzheimer's disease (AD), anxiety disorders, epilepsy, schizophrenia, and autism spectrum disorder (ASD), this article delves into their underlying mechanisms, clinical presentations, diagnostic challenges, and therapeutic interventions. Highlighting the considerable disability and societal costs that these conditions impose, it reflects on the over six million individuals grappling with Alzheimer's, the 19 million American adults living with anxiety disorders, the three million with epilepsy, and the global reach of schizophrenia affecting approximately 20 million people. Furthermore, it examines the emerging landscape of ASD, noting the escalating diagnosis rates and the pressing need for innovative treatments and equitable healthcare access. Through a detailed exploration of current research, technological innovations, and the promise of personalized medicine, this review aims to illuminate the complexities of these conditions, advocate for early intervention strategies, and call for a unified approach to tackling the multifaceted challenges they present. The ultimate goal is to inform and inspire healthcare professionals, researchers, and policymakers to foster advancements that improve outcomes and quality of life for individuals affected by these profound neuropsychiatric disorders, steering towards a future where these conditions are no longer insurmountable. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Grezenko et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu